Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Myiasis caused by Eristalis tenax in Crohn's disease].
Ferrer Bradley I, Navarro Pérez L, Maroto Arce N, López Serrano A, Montón Rodríguez C, Jiménez Mayordomo M, Hinojosa Del Val J. Ferrer Bradley I, et al. Gastroenterol Hepatol. 2010 Oct;33(8):616-7. doi: 10.1016/j.gastrohep.2010.02.010. Gastroenterol Hepatol. 2010. PMID: 20435382 Spanish. No abstract available.
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment.
Barreiro-de Acosta M, Marín-Jimenez I, Rodríguez-Lago I, Guarner F, Espín E, Ferrer Bradley I, Gutiérrez A, Beltrán B, Chaparro M, Gisbert JP, Nos P; en representación de GETECCU. Barreiro-de Acosta M, et al. Among authors: ferrer bradley i. Gastroenterol Hepatol. 2020 Dec;43(10):649-658. doi: 10.1016/j.gastrohep.2020.04.004. Epub 2020 Jun 27. Gastroenterol Hepatol. 2020. PMID: 32600917 Free article. English, Spanish.
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis.
Barreiro-de Acosta M, Gutierrez A, Rodríguez-Lago I, Espín E, Ferrer Bradley I, Marín-Jimenez I, Beltrán B, Chaparro M, Gisbert JP, Nos P; en representación de GETECCU. Barreiro-de Acosta M, et al. Among authors: ferrer bradley i. Gastroenterol Hepatol. 2019 Nov;42(9):568-578. doi: 10.1016/j.gastrohep.2019.08.001. Epub 2019 Oct 9. Gastroenterol Hepatol. 2019. PMID: 31606162 Free article. English, Spanish.
Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents.
Iborra M, Beltrán B, Maroto N, Navarro-Cortés P, Boscá-Watts M, Ferrer-Bradley I, García-Morales N, Sáez-González E, Hinojosa J, Mínguez M, Nos P. Iborra M, et al. Among authors: ferrer bradley i. Gastroenterol Hepatol. 2018 Nov;41(9):535-543. doi: 10.1016/j.gastrohep.2018.06.001. Epub 2018 Jul 19. Gastroenterol Hepatol. 2018. PMID: 30031573 English, Spanish.
Corrigendum to “Recomendaciones del Grupo Español de Trabajo en enfermedad de Crohn y colitis ulcerosa (GETECCU) sobre la reservoritis en la colitis ulcerosa. Parte 2: Tratamiento” [Gastroenterología y Hepatología 2020;43(10):649-658].
Barreiro-de Acosta M, Marín-Jimenez I, Rodríguez-Lago I, Guarner F, Espín E, Ferrer Bradley I, Gutiérrez A, Beltrán B, Chaparro M, Gisbert JP, Nos P; en representación de GETECCU. Barreiro-de Acosta M, et al. Among authors: ferrer bradley i. Gastroenterol Hepatol. 2021 Apr;44(4):320. doi: 10.1016/j.gastrohep.2021.02.001. Epub 2021 Feb 25. Gastroenterol Hepatol. 2021. PMID: 33642094 Free article. English, Spanish. No abstract available.